Immune-checkpoint targeting drug conjugates: a novel class of promising therapeutic
Immune-checkpoint targeting drug conjugates: a novel class of promising therapeutic agents for cancer treatment Summary Immune-checkpoint targeting drug conjugates (ICT-DCs) represent a promising new strategy in cancer treatment. These conjugates combine the precision of immune Read More